This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks Industry Outlook Eastman Chemical, Cabot and Kronos Worldwide
by Zacks Equity Research
Eastman Chemical, Cabot and Kronos Worldwide have been highlighted in this Industry Outlook article.
3 Diversified Chemical Stocks to Escape Industry Headwinds
by Anindya Barman
Demand softness in specific markets, de-stocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. EMN, CBT and KRO are poised to navigate the industry challenges.
Zacks.com featured highlights include Walmart, Agnico Eagle, Booz Allen Hamilton, Vertiv and Cabot
by Zacks Equity Research
Walmart, Agnico Eagle, Booz Allen Hamilton, Vertiv and Cabot have been highlighted in this Screen of The Week article.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
5 Stocks That Boast Solid History of Dividend Growth
by Sweta Killa
Walmart (WMT), Agnico Eagle (AEM), Booz Allen Hamilton (BAH), Vertiv Holdings (VRT) and Cabot (CBT) could be compelling picks given their history of dividend increase.
Should Value Investors Buy Cabot (CBT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes Kronos Worldwide (KRO) Stock a Solid Choice Right Now
by Zacks Equity Research
Kronos Worldwide (KRO) benefits from higher demand for TiO2, improved selling prices and its actions to reduce costs.
Here's Why You Should Hold Onto CF Industries (CF) Stock for Now
by Zacks Equity Research
While softer nitrogen prices weigh on CF Industries' (CF) sales and margins, it benefits from healthy global demand for nitrogen fertilizers and lower natural gas costs.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
While DuPont (DD) faces headwinds from soft demand in certain markets, it benefits from its focus on growth through innovation, the Spectrum Plastics acquisition and productivity actions.
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) benefits from its productivity measures, investments in organic projects, expansion actions and strategic acquisitions amid headwinds from demand softness and pricing pressures.
CBT vs. AIQUY: Which Stock Is the Better Value Option?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
Kronos Worldwide (KRO) Shares Rally 36% in 6 Months: Here's Why
by Zacks Equity Research
Kronos Worldwide (KRO) gains on higher demand for TiO2, improved pricing and its cost-reduction actions.
Do Options Traders Know Something About Cabot (CBT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cabot (CBT) stock based on the movements in the options market lately.
Zacks.com featured highlights include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
by Zacks Equity Research
Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot are part of the Zacks Screen of the Week article.
4 Stocks That Boast Remarkable Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. THC, LDOS, ATO and CBT are sound enough to meet financial obligations.
Zacks.com featured highlights include Leidos, Cabot, Williams-Sonoma, Booz Allen Hamilton and Brady
by Zacks Equity Research
Zacks.com featured highlights include Leidos, Cabot, Williams-Sonoma, Booz Allen Hamilton and Brady
5 Dividend Stocks to Pick for Solid Growth in the Second Half
by Sweta Killa
Leidos Holdings (LDOS), Cabot (CBT), Williams-Sonoma. (WSM), Booz Allen Hamilton (BAH) and Brady (BRC) could be compelling picks heading into the second half of the year.
CBT vs. AIQUY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights DuPont de Nemours, Axalta Coating Systems, Cabot and Kronos Worldwide
by Zacks Equity Research
DuPont de Nemours, Axalta Coating Systems, Cabot and Kronos Worldwide are part the Zacks top Analyst Blog.
4 Top Chemical Stocks to Buy As Destocking Has Run Its Course
by Anindya Barman
A rebound in end-market demand, moderating raw material and energy costs and the absence of customer inventory de-stocking augur well for the chemical industry. DD, AXTA, CBT and KRO are worth a look.
Buy These 4 Stocks With Remarkable Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. THC, STRL, ATO and CBT are sound enough to meet financial obligations.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Has Cabot (CBT) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Cabot (CBT) and AngloGold Ashanti (AU) have performed compared to their sector so far this year.
Is Cabot (CBT) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
Cabot (CBT) Gets Operation Clean Sweep Europe Certification
by Zacks Equity Research
Cabot (CBT) is one of Europe's first black masterbatch manufacturers to receive this third-party certification.